Drug repurposing in cancer

Area of Science:

• Oncology
• Pharmacology
• Drug Discovery

Background:

• Cancer represents a significant global health challenge with increasing incidence.
• Current anti-cancer therapies have limited success, leading to declining FDA approval rates.
• There is a critical need for novel and effective anti-cancer drug development.

Purpose of the Study:

• To provide an overview of promising drug repurposing candidates for cancer treatment.
• To explore the biological mechanisms underlying the anti-neoplastic effects of repurposed drugs.
• To highlight the potential of drug repurposing to address unmet needs in oncology.

Main Methods:

• Review of pre-clinical experimental data.
• Analysis of clinical trial outcomes.
• Evaluation of observational studies on drug efficacy.
• Investigation of molecular mechanisms of action.

Main Results:

• Multiple drug classes, not originally developed for cancer, show significant anti-tumor efficacy.
• Repurposed drugs demonstrate varied mechanisms, including direct cancer cell death induction and suppression of tumor progression.
• Some compounds show potential in preventing cancer development.

Conclusions:

• Drug repurposing is a viable and promising strategy for developing new cancer treatments.
• Understanding the biological mechanisms is crucial for optimizing repurposed drug efficacy.
• This approach holds potential to overcome limitations of traditional anti-cancer drug development.